NTRK1 and cancer: This enzyme could be of prognostic and future therapeutic value NTRK gene fusions (encoding the neurotrophin receptors) are known oncogenic drivers of various tumors and the treatment of NTRK fusion-positive cancers includes the use of tyrosine kinase receptor inhibitors [44, 45].